-
Provivo Biosciences (formerly LPT): animal testing as responsible and animal welfare-oriented as possible
Provivo Biosciences (formerly LPT), a service provider, plans to minimize animal testing at all of its sites by January of next year and work predominantly in vitro.
Written on Wednesday, 20 October 2021 19:22
Read more...
-
New Einstein Center 3R (EC3R) to build trust in 3R research among the scientific community and the public
On July 1, the Einstein Center 3R was launched in Berlin. Its goal is to contribute to reduce or replace animal testing in certain areas of biomedical research with in vitro methods. It will initially be funded with around 5.3 million euros from the Einstein Foundation until the end of 2026. We spoke with the EC3R's head of communications and public relations, Prof. Dr. Jens Kurreck, about the center's tasks and goals.
Written on Friday, 15 October 2021 17:05
Read more...
-
CAAT: Next Generation Humane Science Award - Application Period extended
The Next Generation Humane Science Award of the Center for Alternatives to Animal Testing (CAAT) is available annually to young scientists to acknowledge and encouraging researchers who focus on replacing the use of animals in experiments. The 2021 award will be a prize of up to $5,000 to recognize the work of one young scientist.
Written on Friday, 08 October 2021 09:40
Read more...
-
Mainz: Human platelet lysate as a validated substitute for an animal serum for the assessment of chemosensitivity
For the first time, the University Medical Center Mainz awarded a science prize for young scientists for the development of a culture medium for specific human cells on September 1, 2021. The prize is endowed with 2,500 euros.
Written on Friday, 08 October 2021 09:30
Read more...
-
Pancreatic cancer undone in human cells
A team of researchers at Purdue University in West Lafayette, Indiana, engineered an acinar-on-chip (PAC) from reprogrammed pancreatic cancer cells and induced PTF1a gene expression in the cells. They observed that the cells transitioned to a more normal and differentiated acinar phenotype. The model can be used to study the development and progression of pancreatic cancer.
Written on Wednesday, 06 October 2021 08:59
Read more...
-
Jena: Research to combat infectious diseases
As part of the EU project Inno4Vac (Innovations to accelerate vaccine development and manufacture), the "Inspire" working group from Jena University Hospital will develop immunocompetent organ models. InVitro+Jobs spoke with the head of the Inspire working group at Jena University Hospital, private lecturer Dr. Alexander Mosig.
Written on Thursday, 23 September 2021 09:00
Read more...
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.